biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	C158E76F-672A-4CDB-8E73-BEF81C62FEAF
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-ED-A97K-01A-21R
biospecimen__bio__bcr_portion_barcode	TCGA-ED-A97K-01A-21
biospecimen__bio__bcr_sample_barcode	TCGA-ED-A97K-01A
biospecimen__bio__biospecimen_barcode_bottom	0164105822
biospecimen__bio__day_of_creation	09
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-ED-A97K.518E0619-1C4F-475C-904E-009300CF1768.pdf
biospecimen__bio__plate_column	10
biospecimen__bio__plate_id	A38B
biospecimen__bio__plate_row	C
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-ED-A97K
biospecimen__shared__patient_id	A97K
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	AB426654-2099-411A-AA6A-2DBCAA986530
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	8
clinical__chol_lihc_shared__albumin_result_upper_limit	5.1
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__creatinine_lower_level	4.0
clinical__chol_lihc_shared__creatinine_upper_limit	5.8
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	4.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	20
clinical__chol_lihc_shared__fetoprotein_outcome_value	3
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.3
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	54
clinical__clin_shared__bcr_followup_barcode	TCGA-ED-A97K-F68560
clinical__clin_shared__bcr_followup_uuid	E9A8575A-7B0E-48B7-97D3-980FBD644315
clinical__clin_shared__day_of_form_completion	2
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__platelet_result_count	264
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__shared__histological_type	Hepatocholangiocarcinoma (Mixed)
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	169bde29-467d-44b1-9260-6dc8cfb1e207
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-ED-A97K-01A-21R-A38B-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	67121bdb-cd2a-466f-8c2b-f235a8f03087,8a4a53d5-b3a4-420d-9d8f-daff447f9ea4,5f224628-a591-4525-a19c-2d0b662d19e7
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM,HTSeq - FPKM-UQ,HTSeq - Counts
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	55d8058c-a420-4bb5-a5a8-6bdeae6a5f17
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	8778dc9e-a7db-4464-a8af-11addb5e441a
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:46:38.615520-05:00,2016-05-29T10:46:38.401169-05:00,2016-05-29T10:46:38.142513-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	5be1625f-8bb2-55cd-a064-072814eabcc6
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1959
gdc__diagnoses__age_at_diagnosis	20073
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-20073.0
gdc__diagnoses__days_to_last_follow_up	6.0
gdc__diagnoses__diagnosis_id	82fb6d3a-3b1d-50e1-8fca-37202a0f703e
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8180/3
gdc__diagnoses__primary_diagnosis	Combined hepatocellular carcinoma and cholangiocarcinoma
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	22.14532871972318
gdc__exposures__exposure_id	55881237-d23f-54ed-96e7-07f54cc9a39c
gdc__exposures__height	170.0
gdc__exposures__weight	64.0
gdc__file_id	b4888e08-27c6-4e87-b4f0-59c15ddd0061,1cff5a5d-06d4-49b5-8ad3-3d0546a816a5,be946b00-b11f-4723-96b8-3b57567c1780
gdc__file_name	af5350ea-08b5-4dca-b83c-25a6c70c851c.FPKM.txt.gz,af5350ea-08b5-4dca-b83c-25a6c70c851c.FPKM-UQ.txt.gz,af5350ea-08b5-4dca-b83c-25a6c70c851c.htseq.counts.gz
gdc__file_size	517813,520079,254039
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	0e8835d7b9241614392b2409dfb37291,77177ea34a0c00001bb12be10d0c9609,9a4947761d7ebfc86aad2d07c2b30613
gdc__portions__is_ffpe	false
gdc__portions__portion_id	a0a1e704-9bb7-4bc1-be29-0ba7bf1eb7e4
gdc__portions__portion_number	21
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	92
gdc__samples__initial_weight	1650.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	518E0619-1C4F-475C-904E-009300CF1768
gdc__samples__sample_id	6b015154-d6c7-4aa4-b631-45439cecfb97
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	10.0
gdc__slides__percent_stromal_cells	40.0
gdc__slides__percent_tumor_cells	50.0
gdc__slides__percent_tumor_nuclei	60.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	a9a96647-bf7d-4a85-88e2-12ed38538e44
gdc__submitter_id	af5350ea-08b5-4dca-b83c-25a6c70c851c_fpkm,af5350ea-08b5-4dca-b83c-25a6c70c851c_uqfpkm,af5350ea-08b5-4dca-b83c-25a6c70c851c_count
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	ED
gdc__tissue_source_site__name	Asterand
gdc__tissue_source_site__tissue_source_site_id	8d5c4bc3-5ad6-5c07-8738-a6632e4d59d4
gdc__treatments__treatment_id	f46f6d7b-45bd-5b2f-99f5-46ec6242a59b
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:05:22.611+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/169bde29-467d-44b1-9260-6dc8cfb1e207-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/169bde29-467d-44b1-9260-6dc8cfb1e207-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5135299
manually_curated__local_md5	bdd8efca7886daea740a3556dfa2e1f5
manually_curated__opengdc_download_date	2018-10-15T16:20:19.000725+02:00
manually_curated__opengdc_file_md5	da6215706beda489ae1fc387e8af3cb8
manually_curated__opengdc_file_size	1659451
manually_curated__opengdc_id	169bde29-467d-44b1-9260-6dc8cfb1e207-geq
manually_curated__origin_file_size	5135299
manually_curated__origin_last_modified_date	Mon Oct 15 16:35:00 CEST 2018
manually_curated__origin_md5	bdd8efca7886daea740a3556dfa2e1f5
manually_curated__tissue_status	tumoral
num	60483
